tobramycin has been researched along with Aging in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (30.77) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crass, RL; Pai, MP | 1 |
Allegaert, K; Brussee, JM; Danhof, M; De Cock, RF; de Hoog, M; Knibbe, CA; Mulla, H; Sherwin, CM; van den Anker, JN | 1 |
Holford, N; Kirkpatrick, C; Matthews, I | 1 |
Yaffe, SJ | 1 |
Bauer, LA; Blouin, RA | 1 |
Cipolle, RJ; Seifert, RD; Strate, RG; Zaske, DE | 1 |
Wasfi, IA | 1 |
Bakker, W; Heijerman, HG; Touw, DJ; Vinks, AA | 1 |
Dormans, JA; Dortant, PM; Peters-Volleberg, GW; Speijers, GJ | 1 |
Amorusi, P; Dowell, JA; Korth-Bradley, J; Milisci, M; Tantillo, K; Tse, S | 1 |
Bertino, JS; Etzel, JV; Nafziger, AN | 1 |
Alvestrand, A; Hjelte, L; Larsson, M; Malmborg, AS; Strandvik, B | 1 |
Higa, GM; Murray, WE | 1 |
1 review(s) available for tobramycin and Aging
Article | Year |
---|---|
Antimicrobial therapy and the neonate.
Topics: Absorption; Aging; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Biological Availability; Biotransformation; Cephalosporins; Chloramphenicol; Gentamicins; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kidney; Penicillins; Protein Binding; Tobramycin | 1981 |
1 trial(s) available for tobramycin and Aging
Article | Year |
---|---|
Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Area Under Curve; beta-Lactamase Inhibitors; Creatinine; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Tobramycin | 2001 |
11 other study(ies) available for tobramycin and Aging
Article | Year |
---|---|
Optimizing Estimated Glomerular Filtration Rate to Support Adult to Pediatric Pharmacokinetic Bridging Studies in Patients with Cystic Fibrosis.
Topics: Adolescent; Adult; Aging; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Female; Glomerular Filtration Rate; Humans; Infant; Male; Middle Aged; Models, Biological; Tobramycin; Young Adult | 2019 |
Simultaneous pharmacokinetic modeling of gentamicin, tobramycin and vancomycin clearance from neonates to adults: towards a semi-physiological function for maturation in glomerular filtration.
Topics: Adolescent; Adult; Aging; Body Weight; Child; Child, Preschool; Creatinine; Gentamicins; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Metabolic Clearance Rate; Models, Biological; Tobramycin; Vancomycin | 2014 |
Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides.
Topics: Adult; Aged; Aging; Aminoglycosides; Anti-Bacterial Agents; Body Weight; Creatinine; Female; Gentamicins; Humans; Kidney; Male; Middle Aged; Models, Chemical; Predictive Value of Tests; Tobramycin | 2004 |
Influence of age on tobramycin pharmacokinetics in patients with normal renal function.
Topics: Adult; Aged; Aging; Anti-Bacterial Agents; Bacterial Infections; Female; Half-Life; Humans; Kidney; Kinetics; Male; Middle Aged; Tobramycin | 1981 |
Systematically individualizing tobramycin dosage regimens.
Topics: Adolescent; Adult; Aged; Aging; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Kinetics; Male; Middle Aged; Time Factors; Tobramycin | 1980 |
The effect of endotoxin on tobramycin pharmacokinetics in young and aged rats.
Topics: Aging; Animals; Body Weight; Endotoxins; Escherichia coli; Half-Life; Injections, Intraperitoneal; Male; Rats; Rats, Wistar; Tobramycin | 1993 |
Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosis.
Topics: Adolescent; Adult; Aging; Cystic Fibrosis; Drug Administration Schedule; Drug Delivery Systems; Drug Monitoring; Female; Humans; Male; Models, Biological; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Tobramycin | 1993 |
Ototoxicity of tobramycin in young adult and old rats.
Topics: Aging; Animals; Anti-Bacterial Agents; Cochlea; Dose-Response Relationship, Drug; Female; Hair Cells, Auditory, Inner; Hair Cells, Auditory, Outer; Injections, Subcutaneous; Microscopy, Electron, Scanning; Rats; Rats, Wistar; Specific Pathogen-Free Organisms; Tobramycin | 1996 |
Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.
Topics: Aged; Aging; Body Weight; Female; Fluorescence Polarization Immunoassay; Gentamicins; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Pleural Effusion; Prospective Studies; Regression Analysis; Serum Albumin; Tobramycin | 1992 |
Renal function in rats with essential fatty acid deficiency.
Topics: Aging; Animals; Fatty Acids, Essential; Female; Glomerular Filtration Rate; Kidney; Phospholipids; Potassium; Rats; Rats, Inbred Strains; Sodium; Time Factors; Tobramycin; Urea | 1990 |
Alterations in aminoglycoside pharmacokinetics in patients with cancer.
Topics: Adolescent; Adult; Aging; Anti-Bacterial Agents; Child; Child, Preschool; Female; Gentamicins; Humans; Infant; Leukocyte Count; Male; Neoplasms; Serum Albumin; Sex Factors; Tobramycin | 1987 |